Pair of Bills Target Compound Drugs, Implants

By Greg Jones, Western Bureau Chief Two bills, one in the Assembly and the other in the Senate, aim to control medical costs in California by limiting reimbursement for compound drugs and spinal implants. Assembly Bill 378 declares a need “to remove the financial incentive for prescribing costly and questionable compound drugs, co-packs and medical foods.” The bill, introduced by Rep. Jose Solorio, D-Santa Ana, would add co-packs and medical foods to an existing list of medical goods and services for which a physician can’t make a referral if the physician has a financial int...